Literature DB >> 15963510

Cyclin-dependent kinase 11(p58) interacts with HBO1 and enhances its histone acetyltransferase activity.

Hongliang Zong1, Zejuan Li, Liyun Liu, Yi Hong, Xiaojing Yun, Jianhai Jiang, Yayun Chi, Hanzhou Wang, Xiaoyun Shen, Yun Hu, Ziyue Niu, Jianxin Gu.   

Abstract

CDK11(p58), a 58kDa protein of the PITSLRE kinase family, plays an important role in cell cycle progression, and is closely related to cell apoptosis. To gain further insight into the function of CDK11(p58), we screened a human fetal liver cDNA library for its interacting proteins using the yeast two-hybrid system. Here we report that histone acetyltransferase (HAT) HBO1, a MYST family protein, interacts with CDK11(p58) in vitro and in vivo. CDK11(p58) and HBO1 colocalize in the cell nucleus. Recombinant CDK11(p58) enhances the HAT activity of HBO1 significantly in vitro. Meanwhile, overexpression of CDK11(p58) in mammalian cells leads to the enhanced HAT activity of HBO1 towards free histones. Thus, we conclude that CDK11(p58) is a new interacting protein and a novel regulator of HBO1. Both of the proteins may be involved in the regulation of eukaryotic transcription.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15963510     DOI: 10.1016/j.febslet.2005.05.039

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

1.  Histone acetyltransferase Hbo1: catalytic activity, cellular abundance, and links to primary cancers.

Authors:  Masayoshi Iizuka; Yoshihisa Takahashi; Craig A Mizzen; Richard G Cook; Masatoshi Fujita; C David Allis; Henry F Frierson; Toshio Fukusato; M Mitchell Smith
Journal:  Gene       Date:  2009-02-10       Impact factor: 3.688

Review 2.  Deciphering structure, function and mechanism of lysine acetyltransferase HBO1 in protein acetylation, transcription regulation, DNA replication and its oncogenic properties in cancer.

Authors:  Rongfeng Lan; Qianqian Wang
Journal:  Cell Mol Life Sci       Date:  2019-09-18       Impact factor: 9.261

Review 3.  Cyclin-dependent kinase inhibitor drugs as potential novel anti-inflammatory and pro-resolution agents.

Authors:  A E Leitch; C Haslett; A G Rossi
Journal:  Br J Pharmacol       Date:  2009-09-23       Impact factor: 8.739

4.  CDK11(p58) protein kinase activity is associated with Bcl-2 down-regulation in pro-apoptosis pathway.

Authors:  Xiaojing Yun; Yihong Wu; Luyang Yao; Hongliang Zong; Yi Hong; Jianhai Jiang; Junwu Yang; Zhou Zhang; Jianxin Gu
Journal:  Mol Cell Biochem       Date:  2007-05-22       Impact factor: 3.396

5.  UHRF1-KAT7-mediated regulation of TUSC3 expression via histone methylation/acetylation is critical for the proliferation of colon cancer cells.

Authors:  Kenzui Taniue; Tomoatsu Hayashi; Yuki Kamoshida; Akiko Kurimoto; Yasuko Takeda; Lumi Negishi; Kei Iwasaki; Yoshifumi Kawamura; Naoki Goshima; Tetsu Akiyama
Journal:  Oncogene       Date:  2019-10-03       Impact factor: 9.867

6.  Cyclin D3/CDK11p58 complex is involved in the repression of androgen receptor.

Authors:  Hongliang Zong; Yayun Chi; Yanlin Wang; Yanzhong Yang; Li Zhang; Haijiao Chen; Jianhai Jiang; Zejuan Li; Yi Hong; Hanzhou Wang; Xiaojing Yun; Jianxin Gu
Journal:  Mol Cell Biol       Date:  2007-08-13       Impact factor: 4.272

7.  Hbo1 Links p53-dependent stress signaling to DNA replication licensing.

Authors:  Masayoshi Iizuka; Olga F Sarmento; Takao Sekiya; Heidi Scrable; C David Allis; M Mitchell Smith
Journal:  Mol Cell Biol       Date:  2007-10-22       Impact factor: 5.069

Review 8.  BRPF1-KAT6A/KAT6B Complex: Molecular Structure, Biological Function and Human Disease.

Authors:  Gaoyu Zu; Ying Liu; Jingli Cao; Baicheng Zhao; Hang Zhang; Linya You
Journal:  Cancers (Basel)       Date:  2022-08-23       Impact factor: 6.575

9.  Identification and Functional Characterisation of CRK12:CYC9, a Novel Cyclin-Dependent Kinase (CDK)-Cyclin Complex in Trypanosoma brucei.

Authors:  Séverine Monnerat; Cristina I Almeida Costa; Andrea C Forkert; Corinna Benz; Alana Hamilton; Laurence Tetley; Richard Burchmore; Carlos Novo; Jeremy C Mottram; Tansy C Hammarton
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.